{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:18:00Z","timestamp":1791357480993,"version":"4.3.1"},"reference-count":32,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2004,4,29]],"date-time":"2004-04-29T00:00:00Z","timestamp":1083196800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bipolar Disorders"],"published-print":{"date-parts":[[2004,6]]},"abstract":"<jats:p><jats:bold>Objective:\u2002<\/jats:bold> Evaluate the efficacy and tolerability of quetiapine (QTP) combined with lithium (Li) or divalproex (DVP) in the treatment of acute mania.<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold> Patients were randomized to 21\u2003days of double\u2010blind treatment with QTP plus Li\/DVP, or placebo (PBO) plus Li\/DVP. QTP was rapidly dosed up to a maximum of 800\u2003mg\/day; Li was dosed to 0.7\u20131.0\u2003mEq\/L; or DVP to 50\u2013100\u2003<jats:italic>\u03bc<\/jats:italic>g\/mL.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> Fifty\u2010six of 91 (61.5%) individuals in the QTP\u2003+\u2003Li\/DVP group compared with 49 of 100 (49%) taking PBO\u2003+\u2003Li\/DVP completed the study. A significantly greater mean reduction in total Young Mania Rating Scale (YMRS) score was observed at end\u2010point in patients receiving QTP\u2003+\u2003Li\/DVP compared with those in the PBO\u2003+\u2003Li\/DVP group (\u221213.76 versus \u22129.93; p\u2003=\u20030.021). The response rate (\u226550% YMRS improvement) was significantly higher in the QTP\u2003+\u2003Li\/DVP group than in PBO\u2003+\u2003Li\/DVP\u2010treated patients (54.3% versus 32.6%; p\u2003=\u20030.005), as was the proportion of patients achieving clinical remission (YMRS\u2003&lt;\u200312) (45.7% versus 25.8%; p\u2003=\u20030.007). Patients receiving QTP\u2003+\u2003Li\/DVP also had a significantly greater improvement in Clinical Global Impressions\u2010Bipolar (CGI\u2010BP) Severity of Illness scores (\u22121.38 versus \u22120.78; p\u2003=\u20030.001). The mean last\u2010week dose of QTP was 584\u2003mg\/day in patients meeting response criteria. Common adverse events (at least 10% and twice the rate of Li\/DVP) in the QTP\u2003+\u2003Li\/DVP group included somnolence, dry mouth, asthenia, and postural hypotension.<\/jats:p><jats:p><jats:bold>Conclusions:\u2002<\/jats:bold> Quetiapine combined with either Li or DVP has superior efficacy compared with Li or DVP monotherapy for treating patients with bipolar mania. Combination therapy was well\u2010tolerated and most adverse events were mild, withdrawal because of adverse events being only 5% compared with 6% on Li or DVP monotherapy.<\/jats:p>","DOI":"10.1111\/j.1399-5618.2004.00115.x","type":"journal-article","created":{"date-parts":[[2004,4,29]],"date-time":"2004-04-29T12:34:01Z","timestamp":1083242041000},"page":"213-223","source":"Crossref","is-referenced-by-count":208,"title":["Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double\u2010blind, placebo\u2010controlled study"],"prefix":"10.1111","volume":"6","author":[{"given":"G","family":"Sachs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KNR","family":"Chengappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Suppes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JA","family":"Mullen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Brecher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"NA","family":"Devine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DE","family":"Sweitzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2004,4,29]]},"reference":[{"issue":"13","key":"e_1_2_14_2_2","first-page":"38","article-title":"The economic burden of bipolar disease","volume":"61","author":"Woods SW","year":"2000","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_14_3_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.155.5.646"},{"key":"e_1_2_14_4_2","first-page":"1","article-title":"Practice guideline for the treatment of patients with bipolar disorder (revision)","volume":"159","author":"American Psychiatric Association","year":"2002","journal-title":"Am J Psychiatry"},{"key":"e_1_2_14_5_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v63n0404"},{"key":"e_1_2_14_6_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.321.7272.1302"},{"key":"e_1_2_14_7_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v59n0208"},{"issue":"1","key":"e_1_2_14_8_2","first-page":"S110","article-title":"Quetiapine treatment of rapid\u2010cycling bipolar disorder: an open prospective study","volume":"5","author":"Ghaemi S","year":"2002","journal-title":"Int J Neuropsychopharmacol"},{"key":"e_1_2_14_9_2","unstructured":"DunayevichE TugrulRN StrakowskiSM.Quetiapine in the treatment of mania. Poster presented at the 7th World Congress of Biological Psychiatry July2001 Berlin Germany."},{"key":"e_1_2_14_10_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v61n0307"},{"key":"e_1_2_14_11_2","unstructured":"ChisholmK DennehyE SuppesT.Clinical response to quetiapine add\u2010on for treatment of refractory bipolar disorder. Paper presented at 2nd International Forum on Mood and Anxiety Disorders; November 28\u2013December 1 2001 Monte Carlo Monaco."},{"key":"e_1_2_14_12_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v62n0911"},{"key":"e_1_2_14_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-200210000-00011"},{"key":"e_1_2_14_14_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.159.7.1146"},{"key":"e_1_2_14_15_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.159.6.1011"},{"key":"e_1_2_14_16_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.133.5.429"},{"key":"e_1_2_14_17_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.57.9.841"},{"key":"e_1_2_14_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-1781(97)00123-6"},{"key":"e_1_2_14_19_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.134.4.382"},{"key":"e_1_2_14_20_2","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/13.2.261"},{"key":"e_1_2_14_21_2","doi-asserted-by":"publisher","DOI":"10.1159\/000285058"},{"key":"e_1_2_14_22_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1976.01770060086012"},{"key":"e_1_2_14_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1970.tb02066.x"},{"key":"e_1_2_14_24_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.154.5.672"},{"key":"e_1_2_14_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-977X(00)00140-1"},{"key":"e_1_2_14_26_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-5618.2002.01204.x"},{"issue":"1","key":"e_1_2_14_27_2","first-page":"49","article-title":"Effects of newer and older antidepressants in bipolar depression","volume":"5","author":"Ghaemi SN","year":"2003","journal-title":"Bipolar Disord"},{"key":"e_1_2_14_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(03)80094-2"},{"key":"e_1_2_14_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(97)00190-X"},{"key":"e_1_2_14_30_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291799001476"},{"key":"e_1_2_14_31_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1997.01830180067009"},{"key":"e_1_2_14_32_2","first-page":"74","article-title":"Quetiapine monotherapy versus placebo for acute bipolar mania (STAMP 2)","volume":"5","author":"Paulsson B","year":"2003","journal-title":"Bipolar Disord"},{"key":"e_1_2_14_33_2","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/jama.1994.03510360044034","article-title":"Efficacy of divalproex versus lithium and placebo in the treatment of mania. The Depakote Mania Study Group","volume":"271","author":"Bowden CL","year":"1994","journal-title":"JAMA"}],"container-title":["Bipolar Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1399-5618.2004.00115.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1399-5618.2004.00115.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T12:09:08Z","timestamp":1697198948000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1399-5618.2004.00115.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4,29]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,6]]}},"alternative-id":["10.1111\/j.1399-5618.2004.00115.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1399-5618.2004.00115.x","archive":["Portico"],"relation":{},"ISSN":["1398-5647","1399-5618"],"issn-type":[{"value":"1398-5647","type":"print"},{"value":"1399-5618","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,4,29]]}}}